- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/02 - Linear peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/02
Total number of patents in this class: 693
10-year publication summary
|
33
|
27
|
55
|
57
|
42
|
49
|
47
|
38
|
37
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1153 |
78 |
| Protagonist Therapeutics, Inc. | 139 |
22 |
| Centre National de La Recherche Scientifique | 10564 |
11 |
| SeaGen Inc | 594 |
11 |
| University of South Florida | 1841 |
8 |
| L.e.a.f. Holdings Group LLC | 114 |
8 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 57 |
8 |
| The Regents of the University of California | 20108 |
7 |
| Pfizer Inc. | 3386 |
7 |
| Mersana Therapeutics, Inc. | 103 |
7 |
| Provincial Health Services Authority | 186 |
7 |
| Novartis AG | 10721 |
6 |
| Wisconsin Alumni Research Foundation | 3884 |
6 |
| CARA Therapeutics, Inc. | 49 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4355 |
6 |
| The University of British Columbia | 1512 |
6 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 55 |
6 |
| Bicyclerd Limited | 147 |
6 |
| Genentech, Inc. | 4009 |
5 |
| Takeda Pharmaceutical Company Limited | 2710 |
5 |
| Other owners | 467 |